Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Knight Therapeutics Inc KHTRF


Primary Symbol: T.GUD

Healthcare
Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select... see more

Bullboard (TSX:GUD)

View:
Prev ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... Next
Comment by MrMugsyon Aug 17, 2022 7:57am

RE:RE:RE:Endo Files for Chapter 11

As Samira said in the Q&A ... bankruptcy will be a long process. First we'll wait to see what happens to the company's assets and in who's hands they eventually fall.  Then you ...more  
170
Discussion
Comment by gudisgoodon Aug 17, 2022 4:03am

RE:RE:Endo Files for Chapter 11

Paladin Labs is not worth anywher close to $2B in its current form. From Endo's latest quarterly report, the International segment was flat y/y with YTD sales of $45M. So let's say the yearly ...more  
192
Discussion
Post by gudisgoodon Aug 17, 2022 3:51am

The Gilead Portfolio

Here’s what Samira said about the Gilead portfolio in the Q4/21 earnings call:   So on the termination of agreements, what we did, we know that we -- when it comes to our HIV and HCV ...more  
285
Post by gudisgoodon Aug 17, 2022 3:33am

Q2 Comments

YTD Numbers: YTD growth excluding Exelon was 7.4%. However, since we had some "one-time" sales last year due to Covid treatments, the non-Covid (and non-Exelon) sales grew 17.5 ...more  
266
Comment by CayoLelioon Aug 17, 2022 2:59am

RE:Endo Files for Chapter 11

(LO EDITO QUITANDO LA ORTOGRAFA DE ESPANOL) Hola a todos. Os voy leyendo durante una temporada y servis de mucha ayuda con vuestro gran conocimiento de Knight. Yo tambien estoy en Knight desde hace ...more  
108
Discussion
Comment by CayoLelioon Aug 17, 2022 2:54am

RE:Endo Files for Chapter 11

Hola a todos. Os voy leyendo durante una temporada y servs de mucha ayuda con vuestro gran conocimiento de Knight. Yo tambin estoy en Knight desde hace un ao y sigo de cerca los avances de la empresa. ...more  
141
Discussion
Post by MrMugsyon Aug 17, 2022 12:03am

Endo Files for Chapter 11

Endo International has entered into a restructuring support agreement and filed for Chapter 11 proceedings in the Southern District of New York, according to a statement. Some Endo subsidiaries ...more  
283
Discussion
Comment by wofatson Aug 16, 2022 6:03pm

RE:RE:Interesting - chaotic - fun to watch !!!

This is an option now for a portion . From seeking alpha Endo creditors looking at putting company up for sale through bankruptcy - Bloomberg Endo International (NASDAQ:ENDP) creditors are ...more  
151
Discussion
Post by sylvain_007on Aug 16, 2022 9:33am

the wake UP is coming, UP and UP

WE need volume and if we have a rising volume it's realy good for all.
122
Comment by gudisgoodon Aug 16, 2022 4:47am

RE:RE:RE:Q2 CC snapshot

The average purchase price for all the NCIBs combined is $6.08 a share. As of this moment, we’re in the green for the buybacks, haha. Let’s hope the recent trend continues… but if not, Goodman & ...more  
159
Discussion
Comment by gudisgoodon Aug 16, 2022 4:01am

RE:RE:RE:RE:More than 55 million people Worldwide with dementia

The Exelon acquisition is looking pretty good in my opinion. So far:   $21M of net profit in 2021 (from May -> End of 2021). $19M of net profit YTD ($4.5M sort of “one-time”, so ...more  
131
Discussion
Post by sylvain_007on Aug 15, 2022 3:13pm

flat today, a little breath before a new high for the year

This company can surprise you this year and give you big results, more new to come.
109
Post by sylvain_007on Aug 15, 2022 10:05am

Next direction is 7$ soon

All is going good, so GUD is a leader and the price of the share will continue to rise.
159
Post by GoldenInvestoron Aug 15, 2022 9:03am

Next, the GUD machine takes over in Brazil

Methodically, GUD takes over complete control of Exelon on a country by country basis and we get to watch as it expands.
170
Prev ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities